Dynatronics (NASDAQ:DYNT – Get Rating) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 12th. Analysts expect Dynatronics to post earnings of ($0.09) per share for the quarter. Dynatronics has set its FY 2022 guidance at EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.
Dynatronics (NASDAQ:DYNT – Get Rating) last issued its quarterly earnings data on Thursday, February 10th. The medical equipment provider reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $10.53 million for the quarter. Dynatronics had a return on equity of 12.52% and a net margin of 4.50%. During the same quarter last year, the business earned ($0.06) earnings per share. On average, analysts expect Dynatronics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of DYNT opened at $0.66 on Thursday. The stock’s 50-day simple moving average is $0.72 and its 200 day simple moving average is $0.96. The stock has a market capitalization of $11.84 million, a price-to-earnings ratio of 7.33 and a beta of -0.01. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.30 and a current ratio of 2.38. Dynatronics has a 52-week low of $0.65 and a 52-week high of $1.79.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Citadel Advisors LLC bought a new position in Dynatronics in the 3rd quarter worth about $30,000. Goldman Sachs Group Inc. bought a new position in shares of Dynatronics during the 3rd quarter valued at about $56,000. Millennium Management LLC bought a new position in shares of Dynatronics during the 3rd quarter valued at about $120,000. Finally, Renaissance Technologies LLC increased its position in shares of Dynatronics by 36.8% during the 4th quarter. Renaissance Technologies LLC now owns 1,096,365 shares of the medical equipment provider’s stock valued at $1,096,000 after purchasing an additional 295,200 shares during the last quarter. Institutional investors and hedge funds own 19.46% of the company’s stock.
Dynatronics Company Profile (Get Rating)
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.
- Get a free copy of the StockNews.com research report on Dynatronics (DYNT)
- MarketBeat Podcast: Alternative Investing Strategies Despite Market Volatility
- Limelight Networks Stock is a Speculative Turnaround Opportunity
- The Selloff In SiteOne Landscape Supply Is Overextended
- Camping World Confirms Support At Institutional Bottom
- What’s Next For Starbucks (NASDAQ: SBUX)?
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.